Well the diabetes drug war debates continue . . . see previous posting on Avandia - and here's what's next - Charles
The makers of Actos (pioglitazone), Takeda Pharmaceutical Company Ltd., announced they are to launch a large advertising campaign in the USA for their diabetes drug; following a safety warning issued a day before for Avandia (rosiglitazone), a rival medication.
Local and weekly newspapers throughout the country will feature full-page adverts. The headline will contain the following text׃
"If you have type 2 diabetes, Actos has been shown to lower blood sugar without increasing your risk of having a heart attack or stroke."
Read full article at Medical News Today
No comments:
Post a Comment